NewAmsterdam Pharma
NAMS
NAMS
35 hedge funds and large institutions have $464M invested in NewAmsterdam Pharma in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
20% less capital invested
Capital invested by funds: $581M → $464M (-$117M)
Holders
35
Holding in Top 10
3
Calls
$2.68M
Puts
–
Top Buyers
| 1 | +$13.9M | |
| 2 | +$11.7M | |
| 3 | +$6.21M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$3.97M |
| 5 |
Axa
Paris,
France
|
+$543K |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$1.13M | |
| 3 | -$787K | |
| 4 |
EP
Eversept Partners
New York
|
-$294K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$141K |